Swedbank
MRNA icon

Swedbank’s Moderna MRNA Stock Holding History

Swedbank’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,446
Closed -$95.1K – 687
2025
Q2 		$95.1K Sell
3,446
-16,356
-83% -$431K ﹤0.01% 665
2025
Q1 		$561K Sell
19,802
-74,883
-79% -$2.66M ﹤0.01% 673
2024
Q4 		$3.94M Buy
94,685
+9,586
+11% +$458K ﹤0.01% 572
2024
Q3 		$5.69M Buy
85,099
+51,000
+150% +$4.68M 0.01% 528
2024
Q2 		$4.05M Buy
34,099
+2,993
+10% +$379K 0.01% 558
2024
Q1 		$3.31M Sell
31,106
-1,274
-4% -$128K 0.03% 435
2023
Q4 		$3.22M Buy
32,380
+1,949
+6% +$164K 0.01% 560
2023
Q3 		$3.14M Sell
30,431
-24,024
-44% -$2.68M 0.01% 558
2023
Q2 		$6.62M Sell
54,455
-1,593
-3% -$213K 0.01% 472
2023
Q1 		$8.61M Sell
56,048
-469
-0.8% -$77.4K 0.02% 437
2022
Q4 		$10.2M Sell
56,517
-1,669
-3% -$273K 0.02% 425
2022
Q3 		$6.88M Sell
58,186
-1,731
-3% -$263K 0.02% 454
2022
Q2 		$8.56M Sell
59,917
-9,602
-14% -$1.37M 0.02% 447
2022
Q1 		$12M Sell
69,519
-78,140
-53% -$13.2M 0.02% 419
2021
Q4 		$37.2M Buy
147,659
+77,093
+109% +$22.5M 0.06% 244
2021
Q3 		$27.2M Buy
70,566
+18,958
+37% +$6.99M 0.05% 279
2021
Q2 		$12.1M Buy
51,608
+3,616
+8% +$646K 0.02% 442
2021
Q1 		$6.28M Buy
+47,992
New +$6.95M 0.01% 517

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Swedbank's MRNA Position: Q3 2025 in Review

Swedbank sold out of Moderna (MRNA) in Q3 2025, closing a stake of 3,446 shares — an estimated $95.1K sold.

Swedbank first reported a position in MRNA in Q1 2021 and held it in 18 quarters. The position peaked at $37.2M in Q4 2021. 643 funds tracked by Wall St. Rank hold MRNA as of Q3 2025.

  • Swedbank reported no remaining Moderna position as of Q3 2025 after selling out during the quarter.
  • Swedbank sold 3,446 Moderna shares in Q3 2025, an estimated $95.1K.
  • Swedbank first reported a position in Moderna in Q1 2021 and held it in 18 quarters.
  • Swedbank's Moderna position peaked at $37.2M in Q4 2021.
  • 643 funds tracked by Wall St. Rank held Moderna as of Q3 2025.

Based on Swedbank's 13F filing for Q3 2025, filed 15 Oct 2025.